PET/CT imaging for evaluating response to therapy in castration-resistant prostate cancer Francesco CeciPaolo CastellucciStefano Fanti Editorial Commentary 25 August 2016 Pages: 2103 - 2104
Prospective evaluation of [11C]Choline PET/CT in therapy response assessment of standardized docetaxel first-line chemotherapy in patients with advanced castration refractory prostate cancer Sarah M. SchwarzenböckMatthias EiberBernd J. Krause Original Article 17 June 2016 Pages: 2105 - 2113
Comparison of bone scintigraphy and 68Ga-PSMA PET for skeletal staging in prostate cancer Thomas PykaShozo OkamotoMatthias Eiber Original Article 12 June 2016 Pages: 2114 - 2121
Synthesis and preclinical evaluation of an Al18F radiofluorinated GLU-UREA-LYS(AHX)-HBED-CC PSMA ligand Stefano BoschiJason T. LeeKen Herrmann Original Article 22 June 2016 Pages: 2122 - 2130
Malignant lipogenesis defined by 11C-acetate PET/CT predicts prostate cancer-specific survival in patients with biochemical relapse after prostatectomy Naresh RegulaMichael HäggmanJens Sörensen Original Article 08 July 2016 Pages: 2131 - 2138
Evaluation of tumour hypoxia during radiotherapy using [18F]HX4 PET imaging and blood biomarkers in patients with head and neck cancer Catharina M. L. ZegersFrank J. P. HoebersPhilippe Lambin Original Article Open access 01 June 2016 Pages: 2139 - 2146
The reoxygenation of hypoxia and the reduction of glucose metabolism in head and neck cancer by fractionated radiotherapy with intensity-modulated radiation therapy Shozo OkamotoTohru ShigaNagara Tamaki Original Article 01 June 2016 Pages: 2147 - 2154
TLG-S criteria are superior to both EORTC and PERCIST for predicting outcomes in patients with metastatic lung adenocarcinoma treated with erlotinib Kung-Chu HoYu-Hua Dean FangTzu-Chen Yen Original Article 03 June 2016 Pages: 2155 - 2165
ImmunoPET to help stratify patients for targeted therapies and to improve drug development Françoise Kraeber-BodereClément BaillyJean-François Chatal Editorial Commentary Open access 18 August 2016 Pages: 2166 - 2168
ImmunoPET for assessing the differential uptake of a CD146-specific monoclonal antibody in lung cancer Haiyan SunChristopher G. EnglandWeibo Cai Original Article 25 June 2016 Pages: 2169 - 2179
How reliable is 18FDG PET for predicting the onset of Huntington’s disease? Andrea Ciarmiello Editorial Commentary 10 August 2016 Pages: 2180 - 2182
Striatal hypometabolism in premanifest and manifest Huntington’s disease patients Diego Alfonso López-MoraValle CamachoIgnasi Carrió Original Article 28 June 2016 Pages: 2183 - 2189
Comparison between MRI-based attenuation correction methods for brain PET in dementia patients Jorge CabelloMathias LukasSibylle I. Ziegler Original Article 20 April 2016 Pages: 2190 - 2200
Kinetic analysis of the translocator protein positron emission tomography ligand [18F]GE-180 in the human brain Claire FeeneyGregory ScottDavid J. Sharp Original Article Open access 28 June 2016 Pages: 2201 - 2210
Characterization of the radiolabeled metabolite of tau PET tracer 18F-THK5351 Ryuichi HaradaShozo FurumotoNobuyuki Okamura Original Article 19 July 2016 Pages: 2211 - 2218
Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer’s disease Rawaha AhmadAndrey PostnovKoen Van Laere Original Article 03 August 2016 Pages: 2219 - 2227
18F-FDG PET/CT imaging factors that predict ischaemic stroke in cancer patients Jahae KimKang-Ho ChoiKi-Hyun Cho Original Article 29 July 2016 Pages: 2228 - 2235
Feasibility and acceptance of simultaneous amyloid PET/MRI Lisa SchützDonald LobsienHenryk Barthel Original Article 19 July 2016 Pages: 2236 - 2243
A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism Flavia NiccoliniMarios Politis Review Article Open access 28 July 2016 Pages: 2244 - 2254
Guidelines to PET measurements of the target occupancy in the brain for drug development Akihiro TakanoAndrea VarroneChrister Halldin Guidelines Open access 11 August 2016 Pages: 2255 - 2262
Comments on Van den Wyngaert et al., The EANM practice guidelines for bone scintigraphy Sven-Åke StarckLene Rosendahl Letter to the Editor 25 August 2016 Pages: 2263 - 2264
Strategy based on kinetics of O-(2-[18F] fluoroethyl)-L-tyrosine ([18F] FET) Masashi KameyamaYumi Umeda-Kameyama Letter to the Editor 11 August 2016 Pages: 2267 - 2268
99mTc-DPD-scintigraphy with intense uptake in fat tissue caused by AL-amyloidosis M. ZollerG. HajnosS. Kneifel Image of the Month 28 June 2016 Pages: 2269 - 2270
Paraneoplastic syndrome demonstrated on 99mTc-HMDP bone scan Sophie LancelotFrancesco GiammarileAgnes Tescaru Image of the Month 11 August 2016 Pages: 2271 - 2272
In memoriam: Prof. Ignac Fogelman (04.09.1948 – 05.07.2016) Gopinath GnanasegaranFrédéric PaychaOra Israel Obituary 26 August 2016 Pages: 2273 - 2274